DZ3310A1 - Inhibiteurs de l'echangeur sodium-hydrogene de type 1 - Google Patents

Inhibiteurs de l'echangeur sodium-hydrogene de type 1

Info

Publication number
DZ3310A1
DZ3310A1 DZ013310A DZ013310A DZ3310A1 DZ 3310 A1 DZ3310 A1 DZ 3310A1 DZ 013310 A DZ013310 A DZ 013310A DZ 013310 A DZ013310 A DZ 013310A DZ 3310 A1 DZ3310 A1 DZ 3310A1
Authority
DZ
Algeria
Prior art keywords
nhe
inhibitor
sodium
exchanger type
hydrogen exchanger
Prior art date
Application number
DZ013310A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of DZ3310A1 publication Critical patent/DZ3310A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Plural Heterocyclic Compounds (AREA)
DZ013310A 2000-04-28 2001-02-28 Inhibiteurs de l'echangeur sodium-hydrogene de type 1 DZ3310A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en) 2000-04-28 2001-02-28 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number Publication Date
DZ3310A1 true DZ3310A1 (fr) 2001-11-07

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013310A DZ3310A1 (fr) 2000-04-28 2001-02-28 Inhibiteurs de l'echangeur sodium-hydrogene de type 1

Country Status (40)

Country Link
EP (1) EP1276737A1 (cs)
JP (1) JP2003531900A (cs)
KR (1) KR20020093079A (cs)
CN (1) CN1225466C (cs)
AP (1) AP2002002651A0 (cs)
AR (1) AR028375A1 (cs)
AU (1) AU2001235896A1 (cs)
BG (1) BG107139A (cs)
BR (1) BR0110268A (cs)
CA (1) CA2407535A1 (cs)
CO (1) CO5221125A1 (cs)
CR (1) CR6797A (cs)
CZ (1) CZ20023408A3 (cs)
DZ (1) DZ3310A1 (cs)
EA (1) EA004882B1 (cs)
EE (1) EE200200615A (cs)
GT (1) GT200100064A (cs)
HN (1) HN2001000042A (cs)
HR (1) HRP20020851A2 (cs)
HU (1) HUP0300651A2 (cs)
IL (1) IL152075A0 (cs)
IS (2) IS6567A (cs)
MA (1) MA26897A1 (cs)
MX (1) MXPA02010600A (cs)
MY (1) MY133842A (cs)
NO (1) NO20025132L (cs)
NZ (1) NZ521348A (cs)
OA (1) OA12256A (cs)
PA (1) PA8513301A1 (cs)
PE (1) PE20011270A1 (cs)
PL (1) PL357765A1 (cs)
SK (1) SK14872002A3 (cs)
SV (1) SV2002000418A (cs)
TN (1) TNSN01065A1 (cs)
TR (1) TR200202439T2 (cs)
UA (1) UA73348C2 (cs)
UY (1) UY26680A1 (cs)
WO (1) WO2001083470A1 (cs)
YU (1) YU79602A (cs)
ZA (1) ZA200208605B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004518686A (ja) * 2001-01-31 2004-06-24 ファイザー・プロダクツ・インク ナトリウム−水素交換輸送体1型阻害剤のエタノラート
EP1456181A1 (en) * 2001-12-19 2004-09-15 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
MXPA04008646A (es) * 2002-05-02 2004-12-06 Pfizer Prod Inc Tratamiento para la diabetes y complicaciones diabeticas con inhibidores del nhe-1.
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
MXPA05008612A (es) * 2003-02-14 2005-12-05 Smithkline Beecham Corp Compuestos novedosos.
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU739403B2 (en) * 1998-02-27 2001-10-11 Pfizer Products Inc. N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EE200200615A (et) 2004-04-15
WO2001083470A1 (en) 2001-11-08
UA73348C2 (en) 2005-07-15
HN2001000042A (es) 2001-07-09
HUP0300651A2 (hu) 2003-07-28
HRP20020851A2 (en) 2005-02-28
JP2003531900A (ja) 2003-10-28
IL152075A0 (en) 2003-05-29
UY26680A1 (es) 2001-12-28
TR200202439T2 (tr) 2003-02-21
SV2002000418A (es) 2002-07-03
SK14872002A3 (sk) 2004-03-02
AR028375A1 (es) 2003-05-07
CN1225466C (zh) 2005-11-02
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
MA26897A1 (fr) 2004-12-20
PA8513301A1 (es) 2003-09-05
EA200201023A1 (ru) 2003-02-27
CO5221125A1 (es) 2002-11-28
PE20011270A1 (es) 2001-12-12
GT200100064A (es) 2002-03-22
CR6797A (es) 2004-05-17
BG107139A (bg) 2003-07-31
NO20025132D0 (no) 2002-10-25
AU2001235896A1 (en) 2001-11-12
IS6567A (is) 2002-09-24
EP1276737A1 (en) 2003-01-22
EA004882B1 (ru) 2004-08-26
PL357765A1 (en) 2004-07-26
KR20020093079A (ko) 2002-12-12
ZA200208605B (en) 2003-10-24
MXPA02010600A (es) 2003-03-10
YU79602A (en) 2006-05-25
IS6588A (is) 2002-10-21
AP2002002651A0 (en) 2002-12-31
CZ20023408A3 (cs) 2004-01-14
NO20025132L (no) 2002-12-12
NZ521348A (en) 2004-09-24
BR0110268A (pt) 2003-12-30
TNSN01065A1 (fr) 2005-11-10
MY133842A (en) 2007-11-30
CN1426404A (zh) 2003-06-25

Similar Documents

Publication Publication Date Title
PL349872A1 (en) Heat exchanger
EP1347260A4 (en) HEAT EXCHANGER
EP1347259A4 (en) Heat Exchanger
EP1249586A4 (en) Heat Exchanger
EP1306156A4 (en) THERMAL DIVERS
DZ3310A1 (fr) Inhibiteurs de l'echangeur sodium-hydrogene de type 1
GB2367355B (en) A heat exchanger
HK1048472A1 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
GB0031183D0 (en) Heat exchanger
IL139198A0 (en) Method for preparing sodium-hydrogen exchanger type 1 inhibitor
GB2367886B (en) Heat exchanger
GB0009380D0 (en) Heat exchanger
GB0111114D0 (en) Heat exchanger
GB0026297D0 (en) Heat exchangers
GB0011633D0 (en) Heat exchangers
GB0006080D0 (en) Heat exchanger
GB0009182D0 (en) Heat exchanger
GB0004817D0 (en) Heat exchanger
GB0013054D0 (en) Heat exchanger
GB0021098D0 (en) Heat exchanger
GB0030201D0 (en) Heat exchanger
PL340103A1 (en) Heat exchanger
TW454907U (en) Twin-layer cooling board
GB0029421D0 (en) Drop down radiator MK 5
GB0014058D0 (en) Improved heat exchanger